CELC Stock: $50 Price Target From Canaccord

By Amit Chowdhry ● Oct 11, 2021
  • The shares of Celcuity Inc (NASDAQ: CELC) have received a price target of $50. These are the details.

The shares of Celcuity Inc (NASDAQ: CELC) have received a price target of $50. And Canaccord Genuity analyst Arlinda Lee initiated coverage of Celcuity with a “Buy” rating.

Lee noted that by using live tumor cells from cancer patients, the company’s CELsignia diagnostics platform can dynamically assess signaling activity — which positions it to identify both patients who may benefit from a particular targeted therapy and combinations of drugs that may act synergistically.

With more than 450 patients already dosed and encouraging efficacy and safety in a 138-patient Phase 1b study, Lee is optimistic the pivotal trial starting next year can affirm gedatolisib’s efficacy and support regulatory approval.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.